Summary: Researchers have developed a new substance that activates adrenalin receptors rather than opioid receptors to help relieve chronic pain. The new compounds have similar pain-relieving qualities as opioids but do not appear to induce respiratory depression or addiction.
Source: Friedrich-Alexander-Universitt Erlangen-Nrnberg
New substances that activate adrenalin receptors instead of opioid receptors have a similar pain-relieving effect to opiates, but without the negative aspects such as respiratory depression and addiction.
This is the result of research carried out by an international team of researchers led by the Chair of Pharmaceutical Chemistry at Friedrich-Alexander-Universitt Erlangen-Nrnberg (FAU).
Their findings,which have now been published in the renowned scientific journalScience, are a milestone in the development of non-opioid pain relief.
Opiates cause addiction, new substances do not
They are a blessing for patients suffering from severe pain, but they also have serious side effects: Opioids, and above all morphine, can cause nausea, dizziness and constipation and can also often cause slowed breathing that can even result in respiratory failure.
In addition, opiates are addictive a high percentage of the drug problem in the USA is caused by pain medication, for example.
In order to tackle the unwanted medical and social effects of opioids, researchers all over the world are searching for alternative analgesics.
Prof. Dr. Peter Gmeiner, Chair of Pharmaceutical Chemistry is one of these researchers. We are focusing particularly on the molecular structures of the receptors that dock onto the pharmaceutical substances, says Gmeiner.
It is only when we understand these on the atomic level that we can develop effective and safe active substances.
Collaborating with an international team of researchers, Prof. Gmeiner discovered an active substance in 2016 that bonds to known opioid receptors and that offers the same level of pain relief as morphine, even though it has no chemical similarity to opiates.
New approach: Adrenaline receptors instead of opioid receptors
Peter Gmeiner is currently following a lead that seems very promising: Many non-opioid receptors are involved in pain processing, but only a small number of these alternatives have as yet been validated for use in therapies, he explains.
Gmeiner and a team of researchers from Erlangen, China, Canada and the USA have now turned their attention to a new receptor that is responsible for binding adrenaline the alpha 2A adrenergic receptor. There are already some analgesics that target this receptor such as brimonidine, clonidine and dexmedetomidine.
Gmeiner: Dexmedetomidine relieves pain, but has a strong sedative effect, which means its use is restricted to intensive care in hospital settings and is not suitable for broader patient groups.
The aim of the research consortium is to find a chemical compound that activates the receptor in the central nervous system without a sedative effect. In a virtual library of more than 300 million different and easily accessible molecules, the researchers looked for compounds that physically match the receptor but are not chemically related to known medication.
After a series of complex virtual docking simulations, around 50 molecules were selected for synthesis and testing and two of these fulfilled the desired criteria. They had good bonding characteristics, activated only certain protein sub-types and thus a very selective set of cellular signal pathways, whereas dexmedetomidine responds to a significantly wider range of proteins.
Pain relief without sedation in animal models
By further optimizing the identified molecules, for which extremely high-resolution cryo-electron microscopic imaging was used, the researchers were able to synthesize agonists that produced high concentrations in the brain and reduced the sensation of pain effectively in investigations with animal models.
Various tests confirmed that docking on the receptor was responsible for the analgesic effect, explains Gmeiner. We are particularly pleased about the fact that none of the new compounds caused sedation, even at considerably higher doses than those that would be required for pain relief.
The successful separation of analgesic properties and sedation is a milestone in the development of non-opioid pain medication, especially as the newly-identified agonists are comparatively easy to manufacture and administer orally to patients.
However, Prof. Gmeiner has to dampen any hopes of rapid widespread use in human medicine: We are currently still talking about basic research. The development of medication is subject to strict controls and in addition to significant amounts of funding, it takes a long time. However, these results still make us very optimistic.
Author: Katrin PiechaSource: Friedrich-Alexander-Universitt Erlangen-NrnbergContact: Katrin Piecha Friedrich-Alexander-Universitt Erlangen-NrnbergImage: The image is in the public domain
Original Research: Closed access.Structure-based discovery of nonopioid analgesics acting through the 2A-adrenergic receptor by Peter Gmeiner et al. Science
Abstract
Structure-based discovery of nonopioid analgesics acting through the 2A-adrenergic receptor
Because nonopioid analgesics are much sought after, we computationally docked more than 301 million virtual molecules against a validated pain target, the 2A-adrenergic receptor (2AAR), seeking new 2AAR agonists chemotypes that lack the sedation conferred by known 2AAR drugs, such as dexmedetomidine.
We identified 17 ligands with potencies as low as 12 nanomolar, many with partial agonism and preferential Giand Gosignaling. Experimental structures of 2AAR complexed with two of these agonists confirmed the docking predictions and templated further optimization.
Several compounds, including the initial docking hit 9087 [mean effective concentration (EC50) of 52 nanomolar] and two analogs, 7075 and PS75 (EC504.1 and 4.8 nanomolar), exerted on-target analgesic activity in multiple in vivo pain models without sedation.
These newly discovered agonists are interesting as therapeutic leads that lack the liabilities of opioids and the sedation of dexmedetomidine.
Original post:
Pain Relief Without Side Effects and Addiction - Neuroscience News
- Marcus Neuroscience Institute to Host Brain and Spine Symposium - South Florida Hospital News - March 30th, 2025 [March 30th, 2025]
- Elon University to launch neuroscience major in fall 2025 - Today at Elon - March 30th, 2025 [March 30th, 2025]
- The brains stalwart sentinels express an unexpected gene - The Transmitter: Neuroscience News and Perspectives - March 30th, 2025 [March 30th, 2025]
- Video catches microglia in the act of synaptic pruning - The Transmitter: Neuroscience News and Perspectives - March 30th, 2025 [March 30th, 2025]
- Null and Noteworthy: Reexamining registered reports - The Transmitter: Neuroscience News and Perspectives - March 30th, 2025 [March 30th, 2025]
- Accepting the bitter lesson and embracing the brains complexity - The Transmitter: Neuroscience News and Perspectives - March 30th, 2025 [March 30th, 2025]
- NIH neurodevelopmental assessment system now available as iPad app - The Transmitter: Neuroscience News and Perspectives - March 30th, 2025 [March 30th, 2025]
- Stronger Bonds Before Birth Shape Healthier Mother-Child Futures - Neuroscience News - March 30th, 2025 [March 30th, 2025]
- How Emotionally Intelligent People Learn to Control Their Inner Voice, Backed by Neuroscience - Inc. - March 30th, 2025 [March 30th, 2025]
- Gabriele Scheler reflects on the interplay between language, thought and AI - The Transmitter: Neuroscience News and Perspectives - March 30th, 2025 [March 30th, 2025]
- Worlds first crowd-sourced neuroscience study aims to understand how our brains predict the future - EurekAlert - March 15th, 2025 [March 15th, 2025]
- Rewriting Neuroscience: Possible Foundations of Human Intelligence Observed for the First Time - SciTechDaily - March 15th, 2025 [March 15th, 2025]
- Calculating neurosciences carbon cost: Q&A with Stefan Pulver and William Smith - The Transmitter: Neuroscience News and Perspectives - March 15th, 2025 [March 15th, 2025]
- The future of neuroscience research at U.S. minority-serving institutions is in danger - The Transmitter: Neuroscience News and Perspectives - March 15th, 2025 [March 15th, 2025]
- Dopamine and social media: Why you cant stop scrolling, according to neuroscience - PsyPost - March 15th, 2025 [March 15th, 2025]
- Neuroscience Discovered a Clever Trick for Squeezing More Joy Out of Everyday Pleasures - Inc. - March 15th, 2025 [March 15th, 2025]
- The limits of neuroscience - The Transmitter: Neuroscience News and Perspectives - March 15th, 2025 [March 15th, 2025]
- BPOM Explains The Benefits Of Fasting From The Health And Neuroscience Side - VOI English - March 15th, 2025 [March 15th, 2025]
- How tiny tardigrades could help tackle systems neuroscience questions - The Transmitter: Neuroscience News and Perspectives - March 15th, 2025 [March 15th, 2025]
- Alison Preston explains how our brains form mental frameworks for interpreting the world - The Transmitter: Neuroscience News and Perspectives - March 15th, 2025 [March 15th, 2025]
- The Mystical Mind Meets Neuroscience: Seeking the Roots of Consciousness - Next Big Idea Club Magazine - March 15th, 2025 [March 15th, 2025]
- Myosin Therapeutics Closes Second Seed Round to Advance Clinical Trials for Innovative Cancer and Neuroscience Therapies - PR Newswire - March 5th, 2025 [March 5th, 2025]
- Neuroscience Ph.D. programs adjust admissions in response to U.S. funding uncertainty - The Transmitter: Neuroscience News and Perspectives - March 5th, 2025 [March 5th, 2025]
- New tools help make neuroimaging accessible to more researchers - The Transmitter: Neuroscience News and Perspectives - March 5th, 2025 [March 5th, 2025]
- Future Thinking Training Reduces Impulsivity - Neuroscience News - March 5th, 2025 [March 5th, 2025]
- Null and Noteworthy, relaunched: Probing a schizophrenia biomarker - The Transmitter: Neuroscience News and Perspectives - March 5th, 2025 [March 5th, 2025]
- How to communicate the value of curiosity-driven research - The Transmitter: Neuroscience News and Perspectives - March 5th, 2025 [March 5th, 2025]
- Cognitive neuroscience approach to explore the impact of wind turbine noise on various mental functions - Nature.com - March 5th, 2025 [March 5th, 2025]
- Football on the Brain: Helping coaches embed neuroscience knowledge - Training Ground Guru - March 5th, 2025 [March 5th, 2025]
- Taking Control: Using Neuroscience to Build Better Lives - theLoop - March 5th, 2025 [March 5th, 2025]
- Creating a pipeline of talent to feed the growth of Neuroscience: Lessons from Ghana - Myjoyonline - March 5th, 2025 [March 5th, 2025]
- Exclusive: NIH appears to archive policy requiring female animals in studies - The Transmitter: Neuroscience News and Perspectives - February 25th, 2025 [February 25th, 2025]
- Roll On Down The Highway 2025 Tour coming to Neuroscience Group Field - WeAreGreenBay.com - February 25th, 2025 [February 25th, 2025]
- STEM organizations host Neuroscience Outreach Fair for local K-12 students - University of Virginia The Cavalier Daily - February 25th, 2025 [February 25th, 2025]
- Adapt or die: Safeguarding the future of diversity and inclusion funding in neuroscience - The Transmitter: Neuroscience News and Perspectives - February 25th, 2025 [February 25th, 2025]
- The last two-author neuroscience paper? - The Transmitter: Neuroscience News and Perspectives - February 25th, 2025 [February 25th, 2025]
- Gate Neurosciences Strengthens Focus on the Synapse as a Therapeutic Target with Acquisition of Boost Neuroscience - Business Wire - February 25th, 2025 [February 25th, 2025]
- Why Firefly Neuroscience, Inc. (AIFF) Is Soaring This Year So Far - Yahoo Finance - February 25th, 2025 [February 25th, 2025]
- Breaking the barrier between theorists and experimentalists - The Transmitter: Neuroscience News and Perspectives - February 25th, 2025 [February 25th, 2025]
- Preserving Brain Health and Advancing Neuroscience - University of Miami - February 25th, 2025 [February 25th, 2025]
- Science must step away from nationally managed infrastructure - The Transmitter: Neuroscience News and Perspectives - February 25th, 2025 [February 25th, 2025]
- Repurposed Blood Pressure Drug May Treat ADHD - Neuroscience News - February 25th, 2025 [February 25th, 2025]
- How to teach students about science funding - The Transmitter: Neuroscience News and Perspectives - February 25th, 2025 [February 25th, 2025]
- Reflecting on 2024: Advancing Neuroscience Research to Improve Neurological Health - National Institute of Neurological Disorders and Stroke - February 25th, 2025 [February 25th, 2025]
- Brains Hidden Circuitry for Risk and Reward Uncovered - Neuroscience News - February 25th, 2025 [February 25th, 2025]
- Why We Keep Exploring Even After Learning the Best Strategy - Neuroscience News - February 25th, 2025 [February 25th, 2025]
- Unlocking Cellular Youth: The Protein That Reverses Aging - Neuroscience News - February 25th, 2025 [February 25th, 2025]
- This paper changed my Life: Bill Newsome reflects on a quadrilogy of classic visual perception studies - The Transmitter: Neuroscience News and... - February 25th, 2025 [February 25th, 2025]
- Roundup: The false association between vaccines and autism - The Transmitter: Neuroscience News and Perspectives - February 3rd, 2025 [February 3rd, 2025]
- Static pay, shrinking prospects fuel neuroscience postdoc decline - The Transmitter: Neuroscience News and Perspectives - February 3rd, 2025 [February 3rd, 2025]
- Stimulating the brain with Damien Fair - The Transmitter: Neuroscience News and Perspectives - February 3rd, 2025 [February 3rd, 2025]
- Unhealthy Diet Linked to Faster Biological Aging in Young Adults - Neuroscience News - February 3rd, 2025 [February 3rd, 2025]
- Bob Smittcamp Family Neuroscience Institute coming to Fresno in 2026 - ABC30 News - February 3rd, 2025 [February 3rd, 2025]
- Norton Neuroscience Institute selected to pilot national Brain Health Navigator program - Norton Healthcare - February 3rd, 2025 [February 3rd, 2025]
- Coding bonus: Bats hippocampal cells log spatial, social cues - The Transmitter: Neuroscience News and Perspectives - February 3rd, 2025 [February 3rd, 2025]
- ADHD and brainwaves: How neuroscience is changing the way we diagnose the condition - PsyPost - February 3rd, 2025 [February 3rd, 2025]
- David Robbe challenges conventional notions of time and memory - The Transmitter: Neuroscience News and Perspectives - February 3rd, 2025 [February 3rd, 2025]
- How the Brain Processes Space and Time - Neuroscience News - February 3rd, 2025 [February 3rd, 2025]
- Using neuroscience to help establish healthier habits | Opinion - South Bend Tribune - February 3rd, 2025 [February 3rd, 2025]
- Solvonis chairman on heavy-hitting M&A in neuroscience sector - ICYMI - Proactive Investors UK - February 3rd, 2025 [February 3rd, 2025]
- New neuroscience research sheds light on distinct patterns of learning and generalization in autistic adults - PsyPost - January 23rd, 2025 [January 23rd, 2025]
- Neuroscientists need to do better at explaining basic mental health research - The Transmitter: Neuroscience News and Perspectives - January 23rd, 2025 [January 23rd, 2025]
- How Severance shows the possibilities of cognitive neuroscience - Fast Company - January 23rd, 2025 [January 23rd, 2025]
- AdventHealth Welcomes New Leadership In Heart and Vascular Services, Neuroscience and Orthopedics - Northwest Georgia News - January 23rd, 2025 [January 23rd, 2025]
- School of Neuroscience and Language Sciences Program recognized with University Exemplary Department or Program Award - Virginia Tech - January 23rd, 2025 [January 23rd, 2025]
- Early Exposure to Violent Media Linked to Teen Antisocial Behavior - Neuroscience News - January 23rd, 2025 [January 23rd, 2025]
- The Real Cognitive Neuroscience Behind Severance - WIRED - January 23rd, 2025 [January 23rd, 2025]
- The 15 most popular psychology and neuroscience studies in 2024 - PsyPost - January 1st, 2025 [January 1st, 2025]
- The 'lizard brain' lie: How neuroscience demolished the greatest mind myth - BBC Science Focus - January 1st, 2025 [January 1st, 2025]
- Revolutionizing Brain Diagnostics with Light and AI - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- How Early Experiences Shape Genes, Brain Health, and Resilience - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- A nation exhausted: The neuroscience of why Americans are tuning out political news - Indiana Capital Chronicle - January 1st, 2025 [January 1st, 2025]
- Lithium Restores Brain Function and Behavior in Autism - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- Partners in Diversity presents the science of belonging: exploring the neuroscience of inclusion - Here is Oregon - January 1st, 2025 [January 1st, 2025]
- Classical vs. Operant Conditioning: The Brain's Memory Tug-of-War - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- The Personality Gap Between Singles and the Partnered - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- The Neuroscience Behind Vermeers Girl and Its Hypnotic Power - ZME Science - January 1st, 2025 [January 1st, 2025]
- Serotonin, GABA, and Dopamine Drive Hunger and Feeding - Neuroscience News - December 23rd, 2024 [December 23rd, 2024]
- A nation exhausted: The neuroscience of why Americans are tuning out politics - The Conversation - December 23rd, 2024 [December 23rd, 2024]
- UNO Goalie and Neuroscience Grad Shines in Her Athletic and Academic Aspirations - University of Nebraska Omaha - December 23rd, 2024 [December 23rd, 2024]